We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-0.14%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$167B
AUM Growth
+$3.7B
Cap. Flow
+$8.65B
Cap. Flow %
5.19%
Top 10 Hldgs %
18.31%
Holding
7,698
New
1,245
Increased
2,719
Reduced
2,446
Closed
981

Sector Composition

Rank Sector Weight
1 Technology 7.69%
2 Financials 6.83%
3 Healthcare 6.42%
4 Industrials 4.98%
5 Consumer Discretionary 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FCAC
7601
DELISTED
Falcon Capital Acquisition Corp. Class A Common Stock
FCAC
-838,641
Closed -$7.78M
PRAH
7602
DELISTED
PRA Health Sciences, Inc.
PRAH
-3,730,627
Closed -$616M
NAV
7603
DELISTED
Navistar International
NAV
-1,164,476
Closed -$51.8M
BPFH
7604
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-2,262,412
Closed -$33.4M
TRQ
7605
DELISTED
Turquoise Hill Resources Ltd
TRQ
-144,993
Closed -$2.45M
AXAS
7606
DELISTED
Abraxas Petroleum Corp
AXAS
-53,231
Closed -$172K
AVEO
7607
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-67,700
Closed -$446K
BLPH
7608
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-12,243
Closed -$59K
CFRX
7609
DELISTED
ContraFect Corporation
CFRX
-1,963
Closed -$691K
ONCS
7610
DELISTED
OncoSec Medical Incorporated
ONCS
-1,364
Closed -$84K
ICON
7611
DELISTED
Iconix Brand Group, Inc.
ICON
-160,341
Closed -$502K
GTYH
7612
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
-99,760
Closed -$709K
MACK
7613
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-11,187
Closed -$71K
WPG
7614
DELISTED
Washington Prime Group Inc.
WPG
-27,575
Closed -$60K
NLSN
7615
PUT
DELISTED
Nielsen Holdings plc
NLSN
-18,600
Closed -$459K
OIBR.C
7616
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
-163,617
Closed -$244K
GTT
7617
DELISTED
GTT Communications, Inc.
GTT
-234,689
Closed -$570K
FLY
7618
DELISTED
Fly Leasing Limited
FLY
-1,932,912
Closed -$32.7M
KNL
7619
DELISTED
Knoll, Inc.
KNL
-3,627,935
Closed -$94.3M
LUNA
7620
DELISTED
Luna Innovations Incorporated
LUNA
-20,094
Closed -$218K
LBPH
7621
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
-54,443
Closed -$497K
PUCKU
7622
DELISTED
Goal Acquisitions Corp. Unit
PUCKU
-56,250
Closed -$579K
OPA.U
7623
DELISTED
Magnum Opus Acquisition Limited Units, each consisting of one Class A ordinary share and one-half redeemable warrant
OPA.U
-745,971
Closed -$7.46M
PFSW
7624
DELISTED
PFSweb, Inc.
PFSW
-99,169
Closed -$732K
AGAC.U
7625
DELISTED
African Gold Acquisition Corp Units
AGAC.U
-419,889
Closed -$4.25M

Similar funds

Israel Englander's Q3 2021 Portfolio in Review

As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.

By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $694M trimmed.

  • Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
  • Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
  • Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
  • Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
  • Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
  • Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.